Bandhan BSE Healthcare Index Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return Index
NAV: ₹11.49-1.21%
17 Jul 2026
Loading…
| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 100.02% | 100.24% | 100.04% | 100.01% | 100.07% | 100.16% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | -0.02% | -0.24% | -0.04% | -0.01% | -0.07% | -0.16% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 14,822 | 2.76 | 12.90% | -0.35%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 1,401 | 1.22 | 5.69% | 0.00% |
| Divis Laboratories Ltd. | Healthcare | 1,749 | 1.15 | 5.37% | -0.41%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 10,154 | 1.15 | 5.36% | 0.50%↑ |
| Cipla Ltd. | Healthcare | 7,763 | 1.14 | 5.31% | -0.08%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 8,364 | 1.13 | 5.30% | -0.11%↓ |
| Lupin Ltd. | Healthcare | 3,327 | 0.81 | 3.76% | 0.01%↑ |
| Laurus Labs Ltd. | Healthcare | 5,262 | 0.8 | 3.73% | 0.12%↑ |
| Fortis Healthcare Ltd. | Healthcare | 7,151 | 0.68 | 3.20% | -0.10%↓ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 1,394 | 0.64 | 3.01% | -0.03%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 3,827 | 0.6 | 2.82% | 0.10%↑ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2,053 | 0.45 | 2.11% | -0.21%↓ |
| Alkem Laboratories Ltd. | Healthcare | 804 | 0.45 | 2.09% | -0.10%↓ |
| Biocon Ltd. | Healthcare | 9,791 | 0.41 | 1.91% | -0.22%↓ |
| Mankind Pharma Ltd. | Healthcare | 1,530 | 0.39 | 1.82% | 0.01%↑ |
| Zydus Lifesciences Ltd. | Healthcare | 3,453 | 0.38 | 1.79% | -0.06%↓ |
| Ipca Laboratories Ltd. | Healthcare | 1,915 | 0.33 | 1.52% | 0.08%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 3,628 | 0.28 | 1.33% | 0.02%↑ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 3,406 | 0.28 | 1.30% | 0.02%↑ |
| Gland Pharma Ltd. | Healthcare | 1,086 | 0.27 | 1.26% | 0.05%↑ |
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 99.58% | 99.78% | 99.52% | 99.55% | 99.57% | 99.63% |
| Services | 0.24% | 0.24% | 0.29% | 0.25% | 0.30% | 0.32% |
| Chemicals | 0.20% | 0.22% | 0.23% | 0.21% | 0.20% | 0.21% |
29.2 / 100
Weighted average Value score is 29.2. This indicates that portfolio is relatively reasonably valued using composite of value measures.
76.4 / 100
Weighted average Price Momentum score is 76.4. This indicates that portfolio has high momentum using composite of momentum measures.
85.1 / 100
Weighted average Quality score is 85.1. This indicates that portfolio has high quality using composite of quality measures.
74.7 / 100
Weighted average QVM score is 74.7. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.